Skip to main content
Clinical Trials/JPRN-jRCT2080221521
JPRN-jRCT2080221521UnknownPhase 1

A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Doses of TAS-114 in Healthy Adult Male Subjects

Taiho Pharmaceutical Co., Ltd.0 sites35 target enrollmentStarted: July 25, 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to <= 39age old (—)
Sex
Male

Inclusion Criteria

  • Healthy male subject who have given written informed consent
  • - Subject's age of twenty years old or more and less than forty years old
  • - Subject's weight of 50.0kg or more and BMI (Body Mass Index) of 18.0-25.0kg/m2

Exclusion Criteria

  • - Subject with a history or concurrent status of allergic reaction
  • - Subject with a history or concurrent status of alcoholic or drug addiction
  • - Subject who is not willing to stop smoking during hospitalization
  • - Subject who recieved other investigational drug within 180 days before receiving the study drug

Investigators

Similar Trials